Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYSB2300196	甘精胰岛素利司那肽注射液（Ⅱ）	insulin glargine;lixisenatide	Injection	Biological Products(3.1)	Supplementary Application	2023-11-11					view
JYSB2400100	甘精胰岛素利司那肽注射液（Ⅱ）	insulin glargine;lixisenatide	Injection	Biological Products	Supplementary Application	2024-05-06					view
JYSB2400174	甘精胰岛素利司那肽注射液（Ⅱ）	insulin glargine;lixisenatide	Injection	Biological Products	Supplementary Application	2024-08-09					view
JYSB2400173	甘精胰岛素利司那肽注射液（Ⅰ）	insulin glargine;lixisenatide	Injection	Biological Products	Supplementary Application	2024-08-09					view
JYSB2400099	甘精胰岛素利司那肽注射液（Ⅰ）	insulin glargine;lixisenatide	Injection	Biological Products	Supplementary Application	2024-05-06					view
JXSS2101025	甘精胰岛素利司那肽注射液2:1	insulin glargine;lixisenatide	Injection	Biological Products(3.1)	Import Drug Application	2021-09-30					view
JXSL2101132	甘精胰岛素利司那肽注射液2:1	insulin glargine;lixisenatide	Injection	Biological Products(3.1)	Import Drug Application	2021-11-17					view
JXSL2101131	甘精胰岛素利司那肽注射液1:1	insulin glargine;lixisenatide	Injection	Biological Products(3.1)	Import Drug Application	2021-11-17					view
JXSS2101024	甘精胰岛素利司那肽注射液1:1	insulin glargine;lixisenatide	Injection	Biological Products(3.1)	Import Drug Application	2021-09-29					view
JXSL1700044	甘精胰岛素利司那肽注射液	insulin glargine;lixisenatide	Injection	Biological Products	Import Drug Application	2017-08-10	赛诺菲（中国）投资有限公司	Sanofi (China) Investment Co Ltd	Certificate Issued	2018-08-07	view
JXSL1700045	甘精胰岛素利司那肽注射液	insulin glargine;lixisenatide	Injection	Biological Products	Import Drug Application	2017-08-10	赛诺菲（中国）投资有限公司	Sanofi (China) Investment Co Ltd	Certificate Issued	2018-08-07	view
JXSL1700037	甘精胰岛素利司那肽注射液	insulin glargine;lixisenatide	Injection	Biological Products	Import Drug Application	2017-07-19	赛诺菲（中国）投资有限公司	Sanofi (China) Investment Co Ltd	Certificate Issued	2018-08-07	view
JTH2000217	环酰亚胺-Asp(9)-利司那肽		Active ingredient	Chemical Drugs	Disposable Import Drug Application	2020-08-06	Sanofi-Aventis Deutschland GmbH	Sanofi-Aventis Deutschland GmbH	Certificate Issued	2020-08-25	view
JTH2200022	环酰亚胺-Asp (9)-利司那肽		Active ingredient	Chemical Drugs	Disposable Import Drug Application	2022-02-17					view
JTH2000218	环酰亚胺-Asn (28)-利司那肽		Active ingredient	Chemical Drugs	Disposable Import Drug Application	2020-08-06	Sanofi-Aventis Deutschland GmbH	Sanofi-Aventis Deutschland GmbH	In Review	2020-07-29	view
JTH2200024	环酰亚胺-Asn (28)-利司那肽		Active ingredient	Chemical Drugs	Disposable Import Drug Application	2022-02-18					view
JTH2100625	利司那肽（高分子蛋白系统适用性标准品）	lixisenatide	Other	Chemical Drugs	Disposable Import Drug Application	2021-08-19					view
JTH2200109	利司那肽（高分子蛋白系统适用性标准品）	lixisenatide	Other	Chemical Drugs	Disposable Import Drug Application	2022-06-16					view
JTH2400029	利司那肽（TFA-SSS）	lixisenatide	Active ingredient	Chemical Drugs	Disposable Import Drug Application	2024-03-01					view
JTH2400031	利司那肽（HMWP-SSS）	lixisenatide	Active ingredient	Chemical Drugs	Disposable Import Drug Application	2024-03-01					view